Target 17
Strengthen Biosafety and Distribute the Benefits of Biotechnology
Establish, strengthen capacity for, and implement in all countries in biosafety measures as set out in Article 8(g) of the Convention on Biological Diversity and measures for the handling of biotechnology and distribution of its benefits as set out in Article 19 of the Convention.
Establish, strengthen capacity for, and implement in all countries in biosafety measures as set out in Article 8(g) of the Convention on Biological Diversity and measures for the handling of biotechnology and distribution of its benefits as set out in Article 19 of the Convention.
Rationale
GSAP
Controlling and managing release of genetically modified organisms and other biotechnology products reduces potentially severe impacts on species, their habitats, and people.
Actions
17.1. Implement measures to control or manage and monitor individual impacts of biotechnology on wild species.
17.2. Develop strict protocols to prevent negative effects on wild species from gene editing and genetic manipulation.
Primary tools and resources
The Cartagena Protocol on Biosafety
The Cartagena Protocol on Biosafety is a supplementary international agreement to the Convention on Biological Diversity which aims to ensure the safe handling, transport, and use of living modified organisms (LMOs) resulting from modern biotechnology that may have adverse effects on biological diversity, taking also into account risks to human health. It was adopted on 29 January 2000 and entered into force on 11 September 2003.
The Protocol establishes an advance informed agreement (AIA) procedure for ensuring that countries are provided with the information necessary to make informed decisions before agreeing to the import of such organisms into their territory. The Protocol also establishes a Biosafety Clearing-House to facilitate the exchange of information on living modified organisms and to assist countries in the implementation of the Protocol. The Biosafety Clearing-House is an online platform for exchanging information on living modified organisms and is a key tool for facilitating the implementation of the Cartagena Protocol. It includes national information published by countries (primarily Parties to the Protocol) as well as virtual library of biosafety resources, information on different living modified organisms as well as laboratories for their detection.
How to use
Further information on the Cartagena Protocol is available at: https://bch.cbd.int/protocol
The Biosafety Clearing House can be accessed at: https://bch.cbd.int/en/
